Molecular Modelling a Key Method for Potential Therapeutic Drug Discovery

Area of Science:

• Biochemistry
• Structural Biology
• Pharmacology

Background:

• Protein 3D structure is crucial for understanding biological functions and designing drugs.
• Structure-based drug discovery leverages protein topography to identify pharmacophoric features for therapeutic targets.
• Existing methods for studying drug-protein interactions are often time-consuming and costly.

Purpose of the Study:

• To highlight the underutilization of computational methods in drug discovery.
• To emphasize the potential of in silico approaches for high-throughput screening of drug candidates.
• To demonstrate how bioinformatics can accelerate the identification of potential drugs for genetic targets.

Main Methods:

• Review of traditional methods for studying drug-protein interactions (physical, chromatographic, electrophoretic, spectroscopic).
• Discussion of in silico techniques including docking, molecular simulations, and High-Throughput Virtual Screening (HTVS).
• Bioinformatics approaches for analyzing drug-protein interactions.

Main Results:

• Traditional methods for analyzing drug-protein interactions can be time-consuming and expensive.
• In silico methods offer a powerful, underutilized approach for mass screening of potential drug molecules.
• Analyzing drug-protein interactions computationally can significantly increase the speed of identifying potential drugs.

Conclusions:

• Computational methods like docking and virtual screening are essential for efficient drug discovery.
• Integrating bioinformatics into drug discovery pipelines can accelerate the identification of novel therapeutics.
• Further adoption of in silico tools by drug discovery laboratories is recommended for enhanced efficiency.